Revenue Update on HCP(NYSE:HCP)

HCP(NYSE:HCP) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during Pre-Market on Feb 13, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Company reported revenue of $539.950M. Analysts estimated a revenue of $527.100M. The revenues were 2.44% above the estimates. Earnings per share were $0.59. The reported EPS was above estimates by 126.92%. Analysts had estimated an EPS of $0.26.

In a different note, On Jan 25, 2017, Goldman Sachs said it Upgrades its rating on HCP. According to the research note, Goldman Sachs Raises the price target to $35 per share from a prior target of $29. The shares have been rated ‘Buy’ by the firm. On Dec 13, 2016, BMO Capital said it Upgrades its rating on HCP. The shares have been rated ‘Market Perform’ by the firm.

HCP (HCP) made into the market gainers list on Wednesdays trading session with the shares advancing 0.76% or 0.24 points. Due to strong positive momentum, the stock ended at $31.64, which is also near the day’s high of $31.91. The stock began the session at $31.48 and the volume stood at 41,38,631 shares. The 52-week high of the shares is $36.50149 and the 52 week low is $25.324432. The company has a current market capitalization of $14,813 M and it has 46,81,78,740 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at $40.15 per share price.Also, On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at $40.24 per share price.On Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at $39.20 per share price, according to the Form-4 filing with the securities and exchange commission.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Add Comment